(Q53471405)

14 May 2018

title

Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y12 assay. (English)

1 reference

14 May 2018

author

Choong Hwan Kwak

7

1 reference

14 May 2018

author name string

In-Suk Kim

1

1 reference

14 May 2018

Young-Hoon Jeong

2

1 reference

14 May 2018

Min-Kyung Kang

3

1 reference

14 May 2018

Jin-Sin Koh

4

1 reference

14 May 2018

Yongwhi Park

5

1 reference

14 May 2018

Seok-Jae Hwang

6

1 reference

14 May 2018

Jin-Yong Hwang

8

1 reference

14 May 2018

Sunjoo Kim

9

1 reference

14 May 2018

publication date

1 November 2010

1 reference

14 May 2018

Journal of Thrombosis and Thrombolysis

published in

1 reference

14 May 2018

volume

30

1 reference

14 May 2018

issue

4

1 reference

14 May 2018

page(s)

486-495

1 reference

14 May 2018

The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome.

cites work

1 reference

12 December 2020

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

1 reference

12 December 2020

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

1 reference

12 December 2020

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study

1 reference

12 December 2020

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

1 reference

12 December 2020

Scientific and therapeutic advances in antiplatelet therapy

1 reference

12 December 2020

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study

1 reference

12 December 2020

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

1 reference

12 December 2020

Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness

1 reference

12 December 2020

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents

1 reference

12 December 2020

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

12 December 2020

Platelet function monitoring in patients with coronary artery disease

1 reference

12 December 2020

The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration

1 reference

12 December 2020

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

12 December 2020

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

1 reference

12 December 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

12 December 2020

Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patien

1 reference

12 December 2020

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

1 reference

12 December 2020

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up

1 reference

12 December 2020

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

12 December 2020

Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition

1 reference

12 December 2020

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

1 reference

12 December 2020

Measuring antiplatelet drug effects in the laboratory

1 reference

12 December 2020

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

1 reference

12 December 2020

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

1 reference

12 December 2020

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

1 reference

12 December 2020

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.

1 reference

12 December 2020

Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans.

1 reference

12 December 2020

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

1 reference

12 December 2020

The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay

1 reference

12 December 2020

Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients

1 reference

12 December 2020

10.1007/S11239-010-0484-2

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018